Have a personal or library account? Click to login
Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma Cover

Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma

Open Access
|Feb 2018

References

  1. Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 2011; 89: 716-24. 10.2471/BLT.11.086678
  2. Cancer in Slovenia 2014. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2017.
  3. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141: 52–67. 10.1016/j.cell.2010.03.015
  4. Rawlings ND, Barrett AJ. Evolutionary families of metallopeptidases. Methods Enzymol 1995; 248: 183-228.
  5. Mineo TC, Ambrogi V. Malignant pleural mesothelioma: factors influencing the prognosis. Oncology (Williston Park) 2012; 26: 1164-75.
  6. Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006; 13: 229-37. 10.1245/ASO.2006.03.045
  7. Štrbac D, Goričar K, Dolžan V, Kovač V. Matrix metalloproteinases polymorphisms as prognostic biomarkers in malignant pleural mesothelioma. Dis Markers 2017; 2017: 8069529. Epub 2017 Sep 12. 10.1155/2017/8069529.
  8. Nan H, Niu T, Hunter DJ, Han J. Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 3551-7. 10.1158/1055-9965.EPI-08-0606
  9. Lin CM, Zeng YL, Xiao M, Mei XQ, Shen LY, Guo MX, et al. The relationship between MMP2 -1306C>T and MMP9 -1562C>T polymorphisms and the risk and prognosis of T-cell acute lymphoblastic leukemia in a Chinese population. Cell Physiol Biochem 2017; 42: 1458-68. 10.1159/000479210
  10. Kovač V, Zwitter M, Štrbac D, Goričar K, Rozman A, Kern I, Rajer M. Cisplatin with pemetrexed or gemcitabine in prolonged infusion for inoperable mesothelioma: a phase II randomized trial. [Abstract]. 17th World Conference on Lung Cancer, 4-7 December 2016, Vienna, Austria. J Thorac Oncol 2017; 12(Suppl 1): S715.
  11. National Institute of Environmental health Sciences. SNP Function Prediction (Func Pred). [Internet]. Available at https://snpinfo.niehs.nih.gov/snpinfo/snpfunc.html. Accessed 15 Jan 2017.
  12. Wang J, Cai Y. Matrix metalloproteinase 2 polymorphisms and expression in lung cancer: a meta-analysis. Tumour Biol 2012; 33: 1819-28. 10.1007/s13277-012-0441-0
  13. Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, et al. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Gene 2013; 517: 65-71. 10.1016/j.gene.2012.12.085
  14. Tao L, Li Z, Lin L, Lei Y, Hongyuan Y, Hongwei J, et al. MMP1, 2, 3, 7, and 9 gene polymorphisms and urinary cancer risk: a meta-analysis. Genet Test Mol Biomarkers 2015; 19: 548-55. 10.1089/gtmb.2015.0123
  15. Wieczorek E, Reszka E, Jablonowski Z, Jablonska E, Beata Krol M, Grzegorczyk A, et al. Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility. BJU Int 2013; 112: 1207-14. 10.1111/bju.12230
  16. Sherry ST, Ward MH, M. Kholodov, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308-11.
  17. Tunesi S, Ferrante D, Mirabelli D, Andorno S, Betti M, Fiorito G, et al. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility. Carcinogenesis 2015; 36: 1129-35. 10.1093/carcin/bgv097
  18. Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. The influence of genetic variability on the risk of developing malignant mesothelioma. Radiol Oncol 2018; 52: 105-111. doi: 10.1515/raon-2018-0004
  19. Neri M, Filiberti R, Taioli E, Garte S, Paracchini V, Bolognesi C, et al. Pleural malignant mesothelioma, genetic susceptibility and asbestos exposure. Mutat Res 2005; 592: 36-44. 10.1016/j.mrfmmm.2005.06.003
  20. Franko A, Dolžan V, Arnerić N, Dodič-Fikfak M. The influence of gene-gene and gene-environment interactions on the risk of asbestosis. Biomed Res Int 2013; 2013: 405743. 10.1155/2013/405743
DOI: https://doi.org/10.2478/raon-2018-0005 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 160 - 166
Submitted on: Dec 10, 2017
|
Accepted on: Dec 17, 2017
|
Published on: Feb 7, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Danijela Strbac, Katja Goricar, Vita Dolzan, Viljem Kovac, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.